Becton, Dickinson and Company BDX Medical — Selling and administrative expense

Other segment segments

Similar metrics at other companies

MEIMedical — Selling General And Administrative Expense

$0—

MDTMedical Surgical — Selling, general, and administrative expense

$650M+9.6%

NOVTMedical Solutions — Selling General And Administrative Expense

$16.31M+10.7%

BSXMedSurg — Selling, general and administrative expenses

$557M+8.8%

BSXMedSurg — Selling, general and administrative expenses, percentage of net sale

32.8%+1.0pp

BAXMedical Products & Therapies — Selling, general and administrative expenses

$290M+1.4%

Questions, answered.

What is Becton, Dickinson and Company's medical — selling and administrative expense?

Becton, Dickinson and Company (BDX) reported medical — selling and administrative expense of $328M in Q3 2025.

How has Becton, Dickinson and Company's medical — selling and administrative expense changed year-over-year?

Becton, Dickinson and Company's medical — selling and administrative expense increased by 27.3% year-over-year, from $257.75M to $328M.

What is the long-term trend for Becton, Dickinson and Company's medical — selling and administrative expense?

Over 2 years (2023 to 2025), Becton, Dickinson and Company's medical — selling and administrative expense has grown at a 14.9% compound annual growth rate (CAGR), from $993M to $1.31B.

What does medical — selling and administrative expense mean?

Includes the indirect costs of operating the medical segment, such as sales force compensation, marketing, and general administrative overhead. These expenses support the commercialization and management of the medical product portfolio.